Elevance Health Cost of Goods Sold 2010-2023 | ELV
Elevance Health annual/quarterly cost of goods sold history and growth rate from 2010 to 2023. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Elevance Health cost of goods sold for the quarter ending December 31, 2023 was $36.171B, a 6.89% increase year-over-year.
- Elevance Health cost of goods sold for the twelve months ending December 31, 2023 was $141.623B, a 9.21% increase year-over-year.
- Elevance Health annual cost of goods sold for 2023 was $141.623B, a 9.21% increase from 2022.
- Elevance Health annual cost of goods sold for 2022 was $129.677B, a 14.29% increase from 2021.
- Elevance Health annual cost of goods sold for 2021 was $113.466B, a 16.98% increase from 2020.
| Elevance Health Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $141,623 |
| 2022 | $129,677 |
| 2021 | $113,466 |
| 2020 | $96,998 |
| 2019 | $83,778 |
| 2018 | $71,895 |
| 2017 | $72,236 |
| 2016 | $66,834 |
| 2015 | $61,117 |
| 2014 | $56,855 |
| 2013 | $56,237 |
| 2012 | $48,214 |
| 2011 | $47,648 |
| 2010 | $44,930 |
| 2009 | $47,541 |
| Elevance Health Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023-12-31 | $36,171 |
| 2023-09-30 | $35,254 |
| 2023-06-30 | $35,931 |
| 2023-03-31 | $34,267 |
| 2022-12-31 | $33,841 |
| 2022-09-30 | $32,858 |
| 2022-06-30 | $31,864 |
| 2022-03-31 | $31,114 |
| 2021-12-31 | $30,534 |
| 2021-09-30 | $29,543 |
| 2021-06-30 | $27,377 |
| 2021-03-31 | $26,012 |
| 2020-12-31 | $26,610 |
| 2020-09-30 | $25,143 |
| 2020-06-30 | $21,772 |
| 2020-03-31 | $23,473 |
| 2019-12-31 | $22,532 |
| 2019-09-30 | $21,498 |
| 2019-06-30 | $20,466 |
| 2019-03-31 | $19,282 |
| 2018-12-31 | $18,936 |
| 2018-09-30 | $18,185 |
| 2018-06-30 | $17,728 |
| 2018-03-31 | $17,046 |
| 2017-12-31 | $18,672 |
| 2017-09-30 | $18,104 |
| 2017-06-30 | $17,917 |
| 2017-03-31 | $17,543 |
| 2016-12-31 | $17,568 |
| 2016-09-30 | $16,923 |
| 2016-06-30 | $16,805 |
| 2016-03-31 | $15,539 |
| 2015-12-31 | $16,316 |
| 2015-09-30 | $15,469 |
| 2015-06-30 | $15,205 |
| 2015-03-31 | $14,127 |
| 2014-12-31 | $14,858 |
| 2014-09-30 | $14,211 |
| 2014-06-30 | $14,121 |
| 2014-03-31 | $13,665 |
| 2013-12-31 | $14,581 |
| 2013-09-30 | $14,075 |
| 2013-06-30 | $13,833 |
| 2013-03-31 | $13,749 |
| 2012-12-31 | $12,291 |
| 2012-09-30 | $12,051 |
| 2012-06-30 | $12,100 |
| 2012-03-31 | $11,772 |
| 2011-12-31 | $12,435 |
| 2011-09-30 | $12,063 |
| 2011-06-30 | $11,922 |
| 2011-03-31 | $11,228 |
| 2010-12-31 | $11,357 |
| 2010-09-30 | $11,206 |
| 2010-06-30 | $10,986 |
| 2010-03-31 | $11,382 |
| 2009-12-31 | $12,068 |
| 2009-09-30 | $11,666 |
| 2009-06-30 | $11,971 |
| 2009-03-31 | $11,837 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $122.161B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $44.832B | 17.48 |
| DiDi Global (DIDIY) | China | $24.983B | 0.00 |
| ICON (ICLR) | Ireland | $24.837B | 23.45 |
| Avantor (AVTR) | United States | $16.520B | 24.32 |
| Viatris (VTRS) | United States | $13.812B | 3.97 |
| CochLear (CHEOY) | Australia | $13.622B | 0.00 |
| Revvity (RVTY) | United States | $12.486B | 21.88 |
| Medpace Holdings (MEDP) | United States | $12.117B | 39.86 |
| Charles River Laboratories (CRL) | United States | $11.842B | 21.59 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.592B | 0.00 |
| Natera (NTRA) | United States | $11.317B | 0.00 |
| Solventum (SOLV) | United States | $11.238B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $5.015B | 4.76 |
| Bausch + Lomb (BLCO) | Canada | $4.870B | 19.52 |
| Doximity (DOCS) | United States | $4.537B | 33.78 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.178B | 29.41 |
| Sotera Health (SHC) | United States | $3.088B | 15.15 |
| Progyny (PGNY) | United States | $3.082B | 51.73 |
| Life Times (LTH) | United States | $2.779B | 29.44 |
| GoodRx Holdings (GDRX) | United States | $2.769B | 140.20 |
| Premier (PINC) | United States | $2.543B | 9.31 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.893B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.527B | 0.00 |
| Agiliti (AGTI) | United States | $1.369B | 22.36 |
| Establishment Labs Holdings (ESTA) | $1.359B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.003B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.766B | 7.93 |
| Embecta (EMBC) | United States | $0.589B | 3.89 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.511B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.508B | 0.00 |
| Enhabit (EHAB) | United States | $0.501B | 45.41 |
| Auna S.A (AUNA) | Luxembourg | $0.500B | 0.00 |
| CareDx (CDNA) | United States | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.399B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| Sera Prognostics (SERA) | United States | $0.345B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 5.85 |
| Sharecare (SHCR) | United States | $0.269B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |